iShares Biotechnology ETF (IBB)

NasdaqGM • Currently up 6.01 (+3.00%) in today's trading session

10 members of Congress have disclosed 38 trades in iShares Biotechnology ETF (IBB) via STOCK Act filings. The most recent disclosure was a sale by Bill Foster on 4 September 2025. The most active traders have been Bill Foster (7), Judy Chu (7), and David P. Joyce (6). Aggregate disclosed activity totals roughly $258.5K in purchases and $358K in sales (midpoint estimates from bracketed disclosure amounts).

iShares Biotechnology ETF is currently trading at $206.49, positioned at 84% of its 52-week range ($149.09 – $217.12).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$206.49
24h Change
+6.01 (+3.00%)
52 Week Range
$149.09–$217.12
View on NASDAQ

iShares Biotechnology ETF Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for IBB

Select to highlight on chart
5 transactions
Compliance: 3%
Bill Foster4 Sept 202518 Apr 2026SaleStock$15,001 - $50,000N/A
Angus King27 Jun 202513 May 2026SaleStock$1,001 - $15,000N/A
Bill Foster15 Apr 202518 Apr 2026PurchaseStock$1,001 - $15,000N/A
Bill Foster30 Jan 202518 Apr 2026SaleStock$1,001 - $15,000N/A
Maria Elvira Salazar10 Jan 202513 Aug 2026SaleStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$10.2B

Volume

2.45M

Beta

0.70

P/E Ratio

26.73

Fundamentals

EPS

$7.73

Div. Yield

0.20%

Open

$201.05

Day Range

$200.53 – $206.85

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
NASDAQ · USD
Country
US
IPO Date
2001-02-12
Website
www.ishares.com/us/products/239699/ishares-biotechnology-etf

The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.

Earnings

Recent Quarters

Q2 200915 Aug
EPS-
Q1 200915 May
EPS-
Q4 200816 Feb
EPS-

13 politicians traded within 30 days

Dividends

Dividend History

15 Sept 2026
Amount $0.0112
15 Jun 2026
Amount $0.0238
17 Mar 2026
Amount $0.1218
16 Dec 2025
Amount $0.1831
16 Sept 2025
Amount $0.0828
18 Mar 2025
Amount $0.1212
17 Dec 2024
Amount $0.0624
25 Sept 2024
Amount $0.2005
21 Mar 2024
Amount $0.1260
20 Dec 2023
Amount $0.1240
26 Sept 2023
Amount $0.1532
7 Jun 2023
Amount $0.0062
23 Mar 2023
Amount $0.0646
13 Dec 2022
Amount $0.1010
26 Sept 2022
Amount $0.1590
9 Jun 2022
Amount $0.0310
24 Mar 2022
Amount $0.1180
13 Dec 2021
Amount $0.0410
24 Sept 2021
Amount $0.1240
10 Jun 2021
Amount $0.0232
25 Mar 2021
Amount $0.1310
14 Dec 2020
Amount $0.0650
23 Sept 2020
Amount $0.0630
15 Jun 2020
Amount $0.1270
25 Mar 2020
Amount $0.0550
30 Dec 2019
Amount $0.0630
16 Dec 2019
Amount $0.0580
24 Sept 2019
Amount $0.0710
17 Jun 2019
Amount $0.0800
20 Mar 2019
Amount $0.1270
26 Sept 2018
Amount $0.0320
26 Jun 2018
Amount $0.1561
21 Dec 2017
Amount $0.1250
26 Sept 2017
Amount $0.0397
27 Jun 2017
Amount $0.0589
24 Mar 2017
Amount $0.0997
22 Dec 2016
Amount $0.0307
26 Sept 2016
Amount $0.0287
21 Jun 2016
Amount $0.0541
23 Mar 2016
Amount $0.0509
24 Dec 2015
Amount $0.0107
25 Sept 2015
Amount $0.0007
24 Jun 2015
Amount $0.0193
24 Sept 2014
Amount $0.0180
25 Jun 2014
Amount $0.1311
27 Jun 2013
Amount $0.0241
19 Dec 2012
Amount $0.0343
24 Sept 2012
Amount $0.1133
22 Jun 2012
Amount $0.0621
23 Mar 2012
Amount $0.0091
22 Dec 2011
Amount $0.0047
24 Sept 2010
Amount $0.1700
24 Jun 2008
Amount $0.0589
21 Dec 2006
Amount $0.0003
23 Dec 2005
Amount $0.0003

Stock Splits

Split History

1 Dec 2017Stock Split
Ratio3:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

VTI

Vanguard Morningstar Total Stock Market ETF

77
$381.94+2.38 (+0.63%)
Financial Services
2 politicians both hold this
Same sector: Financial Services
+1 more reason
2 politicians
View Stock

TLT

iShares 20+ Year Treasury Bond ETF

74
$77.98+0.11 (+0.14%)
Financial Services
2 politicians both hold this
Same sector: Financial Services
2 politicians
View Stock

BNDX

Vanguard Total International Bond Index Fund ETF Shares

74
$46.98+0.05 (+0.11%)
Financial Services
2 politicians both hold this
Same sector: Financial Services
2 politicians
View Stock

Frequently Asked Questions about IBB

Which members of Congress have traded IBB?
10 members of Congress have disclosed 38 trades in iShares Biotechnology ETF (IBB) under the STOCK Act. The most active traders are Bill Foster, Judy Chu, and David P. Joyce.
When was IBB most recently disclosed by Congress?
The most recent IBB disclosure was a sale by Bill Foster on 4 September 2025.
What is the total disclosed congressional trading volume for IBB?
Members of Congress have disclosed approximately $258.5K in IBB purchases and $358K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in IBB?
This IBB page updates as soon as new STOCK Act disclosures are filed for iShares Biotechnology ETF. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.